Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.80%
#2 Movement Movement +11.34%
#3 Victoria VR Victoria VR +7.37%
#4 DMT-NAT DMT-NAT +5.95%
#5 Cryptopia Cryptopia +5.23%
#6 COTI COTI +4.96%
#7 Lisk Lisk +4.73%
#8 Pons Pons +4.67%
#9 MarsCoin MarsCoin +4.33%
#10 Jito Jito +3.85%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
Rang in aandelen #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-07-02
Marktkapitalisatie
$2.20K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
CA
Handel Cotinga Pharmaceuticals Inc. (COTQF)

Categorie

Healthcare
Koersgeschiedenis voor Cotinga Pharmaceuticals Inc. (COTQF)
Hoogste slotkoers: $0.00 op 2026-07-01

Laagste slotkoers: $0.42 op 2009-09-01
Koersgeschiedenis van Cotinga Pharmaceuticals Inc. van 2009 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 0.00%
2022 900.00%
2021 -99.99%
2020 3,089.48%
2019 12.40%
2018 -95.52%
2017 -73.25%
2016 53.81%
2015 3.50%
2014 33.09%
2013 16.94%
2012 -61.29%
2011 145.58%
2010 -65.69%
2009 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -7.16%
KR